Abstract:Aim To investigate the association, as well as to characterize the associated panel of pro‐ and anti‐inflammatory markers, between the different components of the peri‐implant phenotype and the presence of peri‐implantitis/peri‐implant soft‐tissue dehiscence (PISTD). Materials and Methods A total of 324 implants in 112 patients were included. The following components of the peri‐implant phenotype were clinically measured through the use of a manual periodontal probe or a digital calliper: keratinized mucosa width (PIKM‐W), mucosal thickness (MT), attached mucosa (AM) and vestibulum depth (VD). The presence of peri‐implantitis and PISTD was assessed through clinical and radiographic examination. Mixed‐models logistic regression analyses were performed to analyse the association between peri‐implant phenotype and the presence of peri‐implantitis or PISTD, adjusting for relevant confounders. Multiplex immunoassays were employed to evaluate the peri‐implant crevicular fluid levels of a panel of pro‐ and anti‐inflammatory markers. Results Peri‐implant health, peri‐implant mucositis and peri‐implantitis were diagnosed in 36.6%, 21.4% and 42% of the patients (classified according to their worst implant) and 35.2%, 34.3%, and 30.5% of the implants, respectively. In the multi‐level multiple regression model, the absence of PIKM‐W (odds ratio [OR] = 9.24; 95% CI: 2.73–31.28), the absence of attached mucosa (OR = 19.58; 95% CI: 6.12–62.56) and a reduced (<4 mm) vestibulum depth (OR = 2.61; 95% CI: 1.05–6.48) were associated with peri‐implantitis. Similarly, the absence of PIKM‐W (OR = 6.32; 95% CI: 1.67–23.83), a thin (<2 mm) mucosa (OR = 157.75; 95% CI: 14.06–1769.9) and a reduced vestibulum depth (OR = 3.32; 95% CI: 1.02–10.84) were associated with the presence of PISTD. Implants with PIKM‐W = 0 mm showed statistically significantly higher levels of interferon‐γ in both regular (≥2 maintenance/year) and irregular (<2 maintenance/year) compliers (p = 0.046 and p = 0.012). In irregular compliers, the absence of PIKM‐W was also associated with statistically significantly higher levels of interleukin (IL)‐1β and IL‐21 (p = 0.016, p = 0.046). These associations were independent of the effect of relevant confounders (e.g., plaque, compliance with maintenance, etc.). Conclusions Within their limits, the present findings indicate that (a) peri‐implant soft‐tissue phenotype appears to be associated with the presence of peri‐implantitis and PISTD, and (b) in the absence of PIKM‐W, the inflammatory response seems to be dysregulated and the soft‐tissue remodelling up‐regulated.

Prevalence, risk indicators, and clinical characteristics of peri-implant mucositis and peri-implantitis for an internal conical connection implant system: A multicenter cross-sectional study

The Characteristics of Microbiome and Cytokines in Healthy Implants and Peri-Implantitis of the Same Individuals

The Occurrence of Peri-Implant Mucositis Associated with the Shift of Submucosal Microbiome in Patients with a History of Periodontitis During the First Two Years.

Patient-, implant- and prosthetic-related factors on peri-implant mucositis and bone loss

Evaluation of Clinical Parameters in Implant Maintenance Phase for Prevention of Peri-implantitis

Influencing Factors Regarding the Severity of Peri-Implantitis and Peri-Implant Mucositis

Microbiological and Functional Traits of Peri-Implant Mucositis and Correlation with Disease Severity.

Study on Prevalence and Risk Indicators for Peri-implant Disease

Incidence and prevalence of peri-implantitis and peri-implant mucositis 17 to 23 (18.9) years postimplant placement.

Microbial profiles of peri-implant mucositis and peri-implantitis: Submucosal microbial dysbiosis correlates with disease severity

Investigation of Peri-Implant Diseases Prevalence and Related Risk Indicators in Patients with Treated Severe Periodontitis over 4 Years after Restoration

Impact of keratinized mucosa on implant‐health related parameters: A 10‐year prospective re‐analysis study

Association of Preventive Maintenance Therapy Compliance and Peri-Implant Diseases: A Cross-Sectional Study

Soft‐Tissue Phenotype as a Risk Indicator of Peri‐Implantitis and Peri‐Implant Soft‐Tissue Dehiscence—A Cross‐Sectional Study

Microbiota of Peri-Implant Healthy Tissues, Peri-Implant Mucositis, and Peri-Implantitis: A Comprehensive Review

The association of clinical and microbiologic parameters with histologic observations in relatively healthy peri-implant conditions- a preliminary short-term in vivo study

Influence of keratinized mucosa width on the resolution of peri‐implant mucositis: A prospective cohort study

Evaluation of peri-implant condition in periodontally compromised patients

The effect of brushing discomfort on peri-implant health in sites exhibiting inadequate keratinized mucosa width: A cross-sectional study

A Retrospective Cohort Study of Risk Factors for Prevalence of Implant Biological Complications

Peri-implant phenotype, calprotectin and MMP-8 levels in cases diagnosed with peri-implant disease